The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review

Roy D Altman, A. Manjoo, A. Fierlinger, F. Niazi, M. Nicholls

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Background: Knee osteoarthritis (OA) is one of the leading causes of disability within the adult population. Current treatment options for OA of the knee include intra-articular (IA) hyaluronic acid (HA), a molecule found intrinsically within the knee joint that provides viscoelastic properties to the synovial fluid. A variety of mechanisms in which HA is thought to combat knee OA are reported in the current basic literature. Methods: We conducted a comprehensive literature search to identify currently available primary non-clinical basic science articles focussing on the mechanism of action of IA-HA treatment. Included articles were assessed and categorized based on the mechanism of action described within them. The key findings and conclusions from each included article were obtained and analyzed in aggregate with studies of the same categorical assignment. Results: Chondroprotection was the most frequent mechanism reported within the included articles, followed by proteoglycan and glycosaminoglycan synthesis, anti-inflammatory, mechanical, subchondral, and analgesic actions. HA-cluster of differentiation 44 (CD44) receptor binding was the most frequently reported biological cause of the mechanisms presented. High molecular weight HA was seen to be superior to lower molecular weight HA products. HA derived through a biological fermentation process is also described as having favorable safety outcomes over avian-derived HA products. Conclusions: The non-clinical basic science literature provides evidence for numerous mechanisms in which HA acts on joint structures and function. These actions provide support for the purported clinical benefit of IA-HA in OA of the knee. Future research should not only focus on the pain relief provided by IA-HA treatment, but the disease modification properties that this treatment modality possesses as well.

Original languageEnglish (US)
Article number321
JournalBMC Musculoskeletal Disorders
Volume16
Issue number1
DOIs
StatePublished - Oct 26 2015
Externally publishedYes

Fingerprint

Hyaluronic Acid
Knee
Knee Osteoarthritis
Joints
Molecular Weight
Biological Phenomena
Synovial Fluid
Proteoglycans
Knee Joint
Glycosaminoglycans
Fermentation
Analgesics
Anti-Inflammatory Agents
Therapeutics
Safety
Pain

Keywords

  • Hyaluronic acid
  • Intra-articular therapy
  • Mechanism of action
  • Osteoarthritis
  • Systematic review
  • Therapy

ASJC Scopus subject areas

  • Rheumatology
  • Orthopedics and Sports Medicine

Cite this

The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee : A systematic review. / Altman, Roy D; Manjoo, A.; Fierlinger, A.; Niazi, F.; Nicholls, M.

In: BMC Musculoskeletal Disorders, Vol. 16, No. 1, 321, 26.10.2015.

Research output: Contribution to journalArticle

Altman, Roy D ; Manjoo, A. ; Fierlinger, A. ; Niazi, F. ; Nicholls, M. / The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee : A systematic review. In: BMC Musculoskeletal Disorders. 2015 ; Vol. 16, No. 1.
@article{f3f196a8ea7a4732a1759beeb9ff6c05,
title = "The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review",
abstract = "Background: Knee osteoarthritis (OA) is one of the leading causes of disability within the adult population. Current treatment options for OA of the knee include intra-articular (IA) hyaluronic acid (HA), a molecule found intrinsically within the knee joint that provides viscoelastic properties to the synovial fluid. A variety of mechanisms in which HA is thought to combat knee OA are reported in the current basic literature. Methods: We conducted a comprehensive literature search to identify currently available primary non-clinical basic science articles focussing on the mechanism of action of IA-HA treatment. Included articles were assessed and categorized based on the mechanism of action described within them. The key findings and conclusions from each included article were obtained and analyzed in aggregate with studies of the same categorical assignment. Results: Chondroprotection was the most frequent mechanism reported within the included articles, followed by proteoglycan and glycosaminoglycan synthesis, anti-inflammatory, mechanical, subchondral, and analgesic actions. HA-cluster of differentiation 44 (CD44) receptor binding was the most frequently reported biological cause of the mechanisms presented. High molecular weight HA was seen to be superior to lower molecular weight HA products. HA derived through a biological fermentation process is also described as having favorable safety outcomes over avian-derived HA products. Conclusions: The non-clinical basic science literature provides evidence for numerous mechanisms in which HA acts on joint structures and function. These actions provide support for the purported clinical benefit of IA-HA in OA of the knee. Future research should not only focus on the pain relief provided by IA-HA treatment, but the disease modification properties that this treatment modality possesses as well.",
keywords = "Hyaluronic acid, Intra-articular therapy, Mechanism of action, Osteoarthritis, Systematic review, Therapy",
author = "Altman, {Roy D} and A. Manjoo and A. Fierlinger and F. Niazi and M. Nicholls",
year = "2015",
month = "10",
day = "26",
doi = "10.1186/s12891-015-0775-z",
language = "English (US)",
volume = "16",
journal = "BMC Musculoskeletal Disorders",
issn = "1471-2474",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee

T2 - A systematic review

AU - Altman, Roy D

AU - Manjoo, A.

AU - Fierlinger, A.

AU - Niazi, F.

AU - Nicholls, M.

PY - 2015/10/26

Y1 - 2015/10/26

N2 - Background: Knee osteoarthritis (OA) is one of the leading causes of disability within the adult population. Current treatment options for OA of the knee include intra-articular (IA) hyaluronic acid (HA), a molecule found intrinsically within the knee joint that provides viscoelastic properties to the synovial fluid. A variety of mechanisms in which HA is thought to combat knee OA are reported in the current basic literature. Methods: We conducted a comprehensive literature search to identify currently available primary non-clinical basic science articles focussing on the mechanism of action of IA-HA treatment. Included articles were assessed and categorized based on the mechanism of action described within them. The key findings and conclusions from each included article were obtained and analyzed in aggregate with studies of the same categorical assignment. Results: Chondroprotection was the most frequent mechanism reported within the included articles, followed by proteoglycan and glycosaminoglycan synthesis, anti-inflammatory, mechanical, subchondral, and analgesic actions. HA-cluster of differentiation 44 (CD44) receptor binding was the most frequently reported biological cause of the mechanisms presented. High molecular weight HA was seen to be superior to lower molecular weight HA products. HA derived through a biological fermentation process is also described as having favorable safety outcomes over avian-derived HA products. Conclusions: The non-clinical basic science literature provides evidence for numerous mechanisms in which HA acts on joint structures and function. These actions provide support for the purported clinical benefit of IA-HA in OA of the knee. Future research should not only focus on the pain relief provided by IA-HA treatment, but the disease modification properties that this treatment modality possesses as well.

AB - Background: Knee osteoarthritis (OA) is one of the leading causes of disability within the adult population. Current treatment options for OA of the knee include intra-articular (IA) hyaluronic acid (HA), a molecule found intrinsically within the knee joint that provides viscoelastic properties to the synovial fluid. A variety of mechanisms in which HA is thought to combat knee OA are reported in the current basic literature. Methods: We conducted a comprehensive literature search to identify currently available primary non-clinical basic science articles focussing on the mechanism of action of IA-HA treatment. Included articles were assessed and categorized based on the mechanism of action described within them. The key findings and conclusions from each included article were obtained and analyzed in aggregate with studies of the same categorical assignment. Results: Chondroprotection was the most frequent mechanism reported within the included articles, followed by proteoglycan and glycosaminoglycan synthesis, anti-inflammatory, mechanical, subchondral, and analgesic actions. HA-cluster of differentiation 44 (CD44) receptor binding was the most frequently reported biological cause of the mechanisms presented. High molecular weight HA was seen to be superior to lower molecular weight HA products. HA derived through a biological fermentation process is also described as having favorable safety outcomes over avian-derived HA products. Conclusions: The non-clinical basic science literature provides evidence for numerous mechanisms in which HA acts on joint structures and function. These actions provide support for the purported clinical benefit of IA-HA in OA of the knee. Future research should not only focus on the pain relief provided by IA-HA treatment, but the disease modification properties that this treatment modality possesses as well.

KW - Hyaluronic acid

KW - Intra-articular therapy

KW - Mechanism of action

KW - Osteoarthritis

KW - Systematic review

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84945261984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945261984&partnerID=8YFLogxK

U2 - 10.1186/s12891-015-0775-z

DO - 10.1186/s12891-015-0775-z

M3 - Article

C2 - 26503103

AN - SCOPUS:84945261984

VL - 16

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

SN - 1471-2474

IS - 1

M1 - 321

ER -